LS

Lokendra Singh

Active Director Director DIN 11243832
DIN 11243832 First appointment Aug 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Lokendra Singh

Data last updated:

Lokendra Singh is a Director at Aarnaallayans Micro Services Foundation (since 2025) and Director at Globaxia Pharma Private Limited (since 2025).

DIN 11243832
Primary Designation Director
First Appointment 14 Aug 2025
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Aug 20252024Active
Globaxia Pharma Private Limited U46497DL2025PTC453260
Director14 Aug 20252025Active

Directorship timeline

Open interactive timeline →
Aarnaallayans Micro Services Foundation
Globaxia Pharma Private Limited
Premium access

Shareholding and investment profile for Lokendra Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lokendra Singh

Lokendra Singh currently holds 2 directorships: Aarnaallayans Micro Services Foundation (Director, since 19 Aug 2025); Globaxia Pharma Private Limited (Director, since 14 Aug 2025).

Lokendra Singh was first appointed on 14 Aug 2025 as Director at Globaxia Pharma Private Limited.

The current boards of Lokendra Singh's companies include Kusum Nayak (Aarnaallayans Micro Services Foundation), Pawan Namdev (Globaxia Pharma Private Limited), Vipin Kumar Aggarwal (Globaxia Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available